title: [Current recommendations for the treatment of chronic hepatitis C].
authors.forename: Christoph
authors.initials: C
authors.lastname: Sarrazin
authors.forename: Thomas
authors.initials: T
authors.lastname: Berg
authors.forename: Peter
authors.initials: P
authors.lastname: Buggisch
authors.forename: Matthias
authors.initials: M
authors.lastname: Dollinger
authors.forename: Holger
authors.initials: H
authors.lastname: Hinrichsen
authors.forename: Dietrich
authors.initials: D
authors.lastname: Hüppe
authors.forename: Michael
authors.initials: M
authors.lastname: Manns
authors.forename: Stefan
authors.initials: S
authors.lastname: Mauss
authors.forename: Jörg
authors.initials: J
authors.lastname: Petersen
authors.forename: Karl-Georg
authors.initials: KG
authors.lastname: Simon
authors.forename: Ingo
authors.initials: I
authors.lastname: van Thiel
authors.forename: Heiner
authors.initials: H
authors.lastname: Wedemeyer
authors.forename: Stefan
authors.initials: S
authors.lastname: Zeuzem
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D000998:Antiviral Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D005858:Germany; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D006801:Humans; D055552:Infectious Disease Medicine / Q000592:standards*; D017410:Practice Guidelines as Topic; D014773:Virology / Q000592:standards*
chemical_list: D000911:Antibodies, Monoclonal; D000998:Antiviral Agents